Stopped: Thirty-five subjects wore the EAS processor for as long as 84 months without significant safety issues. Sufficient data gained to support EAS technology development for safe use in subjects with residual low-frequency acoustic hearing sensitivity.
The purpose of this feasibility study is to evaluate whether low-frequency acoustic hearing sensitivity can be preserved in newly implanted adults with partial deafness (considerable low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural hearing loss) using the HiResolution™ 90K™ Advantage cochlear implant with the HiFocus™ Mid-Scala electrode to support the development of electro-acoustic stimulation technology (EAS).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Unaided Pure-tone Average (PTA) Hearing Threshold Measurements
Timeframe: Twelve months post device activation
Consonant-Nucleus-Consonant (CNC) Word Recognition Test in Quiet
Timeframe: Up to 12 months post device activation
Speech Perception Testing (AzBio) in Noise.
Timeframe: up to 12 months post device activation